The Anatomy of the Bronchioles

Anatomy of the lungs

 Patrick J. Lynch / Wikimedia Commons

Table of Contents
View All
Table of Contents

Bronchioles are air passages inside the lungs that branch off like tree limbs from the bronchi—the two main air passages into which air flows from the trachea (windpipe) after being inhaled through the nose or mouth.

The bronchioles deliver air to tiny sacs called alveoli where oxygen and carbon dioxide are exchanged. They are vulnerable to conditions like asthma, bronchiolitis, cystic fibrosis, and emphysema that can cause constriction and/or obstruction of the airways.


The bronchioles are part of the lower respiratory system. As they branch off from the bronchi, they become smaller and smaller, traversing the interior of each lung before ending at clusters of alveoli. There are three types, categorized by size:

  • Lobular bronchioles (larger passages that first enter the lobes of the lungs)
  • Respiratory bronchioles (two or more branches from each terminal bronchiole that, in turn, lead to two to 10 alveolar ducts)
  • Terminal bronchioles (50 to 80 smaller passages in each lung)

The lobular and terminal bronchioles are sometimes referred to as "dead space" because no air exchange occurs in these passages.

The bronchioles themselves are tiny, ranging from 0.3 to 1 mm in diameter.


Bronchioles rely on bundles of protein fibers, called elastin, to hold their shape by anchoring themselves into lung tissue.

The lining of the bronchioles, called lamina propria, is thin and surrounded by a layer of smooth muscle that contracts when the flow of blood is decreased and dilates when the flow of blood is increased.

The walls of the bronchioles are also lined with tiny finger-like projections, called cilia, whose function is to move debris and microbes out of the airways. The density of cilia decreases as the bronchioles branch off and get smaller and smaller.

The bronchioles are lined with club cells that secrete surfactants—compounds that reduce surface tension within airways, allowing them to expand during inhalation and preventing them from collapsing during exhalation.

Club cells also secrete enzymes that break down debris and irritants so that they can be readily excreted from the lung.


The function of the bronchioles is to deliver air to a diffuse network of around 300 million alveoli in the lungs. As you inhale, oxygenated air is pulled into the bronchioles. Carbon dioxide collected by the alveoli is then expelled from the lungs as you exhale.

The bronchioles are not inert. The smooth muscles that surround the airways will automatically constrict (close) and dilate (open) to control the flow of air in and out of the lungs.

Associated Conditions

Dilation of the airways (bronchodilation) occurs when the lungs need more oxygen, such as during exercise or at higher altitudes.

By contrast, narrowing of the airways, bronchoconstriction, can occur when irritants or allergens are inhaled. While this is meant to keep foreign substances from entering the lungs, it can restrict breathing, sometimes severely. Certain medications, inflammation, and disease can do the same.

Symptoms of bronchoconstriction include:

  • Breathing difficulty and shortness of breath
  • Chest tightness
  • Coughing
  • Cyanosis (bluish skin due to the lack of oxygen)
  • Extreme tiredness with physical activity
  • Wheezing

Bronchoconstriction may be accompanied by bronchiolar obstruction caused when the airways are blocked, as from the overproduction of mucus. Symptoms of bronchiolar obstruction can overlap with those of bronchoconstriction and include:

  • A chronic productive cough
  • Chest tightness
  • Cyanosis
  • Repeated respiratory infections
  • Wheezing

The following conditions involve the bronchioles:


Asthma is an allergic condition triggered primarily by allergens or irritants in the air and, in children, respiratory infections. When allergens enter the bronchioles, a type of immune cell called a mast cell releases a substance called histamine that causes smooth muscles of the bronchioles to contract.


Bronchiolitis is inflammation of the bronchioles. It's most common in babies between 3 months and 6 months of age who become infected with a virus such as respiratory syncytial virus (RSV) or influenza.

Bronchiolitis Obliterans

Bronchiolitis obliterans is a rare inflammatory condition that causes scarring (fibrosis) of the bronchioles to the extent that the airways are blocked.

Nicknamed "popcorn lung," bronchiolitis obliterans primarily affects adults and may be caused by:

  • Excessive or prolonged exposure to toxins such as ammonia, chlorine, formaldehyde, sulfur dioxide, nicotine, diacetyl (used for butter flavoring), and acetaldehyde (found in e-cigarettes)
  • Organ transplants
  • Prolonged inhalation of fiberglass particles or fly ash from coal;
  • Rheumatoid arthritis and other autoimmune diseases.
  • Viral lung infections, including coronavirus (COVID-19)

Bronchiolitis obliterans is irreversible: In severe cases a lung transplant may be needed.

Cystic Fibrosis

Cystic fibrosis is an inherited, life-threatening disorder that damages the lungs and digestive system.

Cystic fibrosis causes goblet cells to produce excessive amounts of mucus that clogs tubes, ducts, and passages in the respiratory and gastrointestinal tracts. As the disease advances, it can cause scarring of the bronchioles as well as the collapse of the lung (atelectasis).

There is no cure for cystic fibrosis, but it can be slowed with medications, antibiotics, physical therapies, and preventive vaccinations.


Emphysema is one manifestation of congestive obstructive pulmonary disease (COPD), a group of lung diseases that block airflow and make it difficult to breathe. In emphysema, damage to the alveoli and lung tissue causes the bronchioles to collapse.

The leading cause of emphysema is smoking. Others include air pollution, secondhand smoke, chronic respiratory infections, and occupational exposure to dust and chemicals.

Emphysema can't be reversed but it can be treated with bronchodilators, anti-inflammatory drugs, supplemental oxygen, and surgery to remove damaged tissue.

Treatment and Rehabilitation

The course and duration of bronchiolar rehabilitation can vary based on whether the condition is restrictive and/or obstructive. Some treatments are designed to alleviate acute episodic symptoms (called exacerbations), while others prevent the worsening or recurrence of symptoms.

Restrictive Disorders

With bronchoconstriction, rehabilitative and treatment options include:

  • Avoidance of triggers such as allergens or environmental pollutants. This is a key aspect of asthma treatment.
  • Biologic drugs, like Xolair (omalizumab) that block the release of histamine in people for whom antihistamines do not work
  • Bronchodilators, taken orally or inhaled to open airways, including beta-adrenergic agonists like albuterol, anticholinergics like Spiriva (tiotropium), and methylxanthines like aminophylline
  • Inhaled corticosteroids, like Flovent HFA (fluticasone) or QVAR RediHaler (beclomethasone) to reduce the frequency and severity of exacerbations
  • Oral corticosteroids such as prednisone to treat acute exacerbations
  • Oral leukotriene modifiers, like Singulair (montelukast) and Zyflo (zileuton) that help control inflammation in the airway

Obstructive Disorders

Acute conditions, like bronchiolitis, may only need short-term treatment to resolve the underlying infection.

Chronic bronchiolar obstruction, such as occurs with COPD and cystic fibrosis, typically require medications, physical therapies, and supportive care to slow disease progression. Surgery sometimes is needed.

The rehabilitative and treatment options for bronchiolar obstruction include:

  • Airway clearance devices, including high-intensity oscillators or positive expiratory pressure (PEP) to aid in mucus clearance
  • Bronchodilators to open airways blocked by the accumulation of mucus
  • Diaphragmatic breathing—inhaling and exhaling with the abdomen rather than the chest to increase lung capacity
  • Inhaled corticosteroids to reduce inflammation caused by obstruction
  • Mucolytics that thin mucus so it can be coughed up more easily
  • Nasal suctioning to remove excess mucus from the nasal passages and upper respiratory tract
  • Oxygen therapy, to provide supplemental oxygen to those with chronic breathing difficulty, either on a full-time basis or as needed
  • Pulmonary rehabilitation, including techniques like postural drainage and percussion, to regularly clear mucus in people with chronic bronchiolar obstruction

In addition, many people with chronic obstructive disorders like COPD and cystic fibrosis may find 20 to 30 minutes of physical exercise five days per week is a useful part of treatment.

14 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Chaudhry R, Bordoni B. Anatomy, thorax, lungs. In: StatPearls.

  2. Lee JW, Son JS, Choi JW, Han YJ, Lee JR. The comparison of the lengths and diameters of main bronchi measured from two-dimensional and three-dimensional images in the same patients. Korean J Anesthesiol. 2014;66(3):189–194. doi:10.4097/kjae.2014.66.3.189

  3. Mecham RP. Elastin in lung development and disease pathogenesisMatrix Biol. 2018;73:6–20. doi:10.1016/j.matbio.2018.01.005

  4. Rokicki W, Rokicki M, Wojtacha J, Dżeljijli A. The role and importance of club cells (Clara cells) in the pathogenesis of some respiratory diseases. Kardiochir Torakochirurgia Pol. 2016;13(1):26-30. doi:10.5114/kitp.2016.58961

  5. Wagner PD. The physiological basis of pulmonary gas exchange: implications for clinical interpretation of arterial blood gases. Eur Respir J. 2015;45(1):227-43. doi:10.1183/09031936.00039214

  6. D'Amato M, Molino A, Calabrese G, Cecchi L, Annesi-Maesano I, D'Amato G. The impact of cold on the respiratory tract and its consequences to respiratory health. Clin Transl Allergy. 2018;8:20. doi:10.1186/s13601-018-0208-9

  7. Busse WW, Lemanske RF Jr, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet. 2010;376(9743):826–834. doi:10.1016/S0140-6736(10)61380-3

  8. Piedimonte G, Perez MK. Respiratory syncytial virus infection and bronchiolitis [published correction appears in Pediatr Rev. 2015 Feb;36(2):85]. Pediatr Rev. 2014;35(12):519–530. doi:10.1542/pir.35-12-519

  9. National Center for Advancing Translational Sciences/National Institutes of Health. Bronchiolitis obliterans.

  10. Boon M, Verleden SE, Bosch B, et al. Morphometric analysis of explant lungs in cystic fibrosis. Am J Respir Crit Care Med. 2016;193(5):516-26. doi:10.1164/rccm.201507-1281OC 

  11. Martin C, Frija J, Burgel PR. Dysfunctional lung anatomy and small airways degeneration in COPDInt J Chron Obstruct Pulmon Dis. 2013;8:7–13. doi:10.2147/COPD.S28290

  12. Cukic V, Lovre V, Dragisic D, Ustamujic A. Asthma and chronic obstructive pulmonary disease (COPD) - Differences and similaritiesMater Sociomed. 2012;24(2):100–105. doi:10.5455/msm.2012.24.100-105

  13. Oberg C, Folch E, Santa Cruz JF. Management of malignant airway obstruction. AMJ. 2018 Dec;3:11.06. doi:10.21037/amj.2018.11.06

  14. Spruit MA, Burtin C, De Boever P, et al. COPD and exercise: does it make a difference?Breathe (Sheff). 2016;12(2):e38–e49. doi:10.1183/20734735.003916

By Lynne Eldridge, MD
 Lynne Eldrige, MD, is a lung cancer physician, patient advocate, and award-winning author of "Avoiding Cancer One Day at a Time."